Literature DB >> 24302484

Dynamic permeability and quantitative susceptibility: related imaging biomarkers in cerebral cavernous malformations.

Abdul Ghani Mikati1, Huan Tan, Robert Shenkar, Luying Li, Lingjiao Zhang, Xiaodong Guo, Henrik B W Larsson, Changbin Shi, Tian Liu, Yi Wang, Akash Shah, Robert R Edelman, Gregory Christoforidis, Issam Awad.   

Abstract

BACKGROUND AND
PURPOSE: Hyperpermeability and iron deposition are 2 central pathophysiological phenomena in human cerebral cavernous malformation (CCM) disease. Here, we used 2 novel MRI techniques to establish a relationship between these phenomena.
METHODS: Subjects with CCM disease (4 sporadic and 17 familial) underwent MRI imaging using the dynamic contrast-enhanced quantitative perfusion and quantitative susceptibility mapping techniques that measure hemodynamic factors of vessel leak and iron deposition, respectively, previously demonstrated in CCM disease. Regions of interest encompassing the CCM lesions were analyzed using these techniques.
RESULTS: Susceptibility measured by quantitative susceptibility mapping was positively correlated with permeability of lesions measured using dynamic contrast-enhanced quantitative perfusion (r=0.49; P≤0.0001). The correlation was not affected by factors, including lesion volume, contrast agent, and the use of statin medication. Susceptibility was correlated with lesional blood volume (r=0.4; P=0.0001) but not with lesional blood flow.
CONCLUSIONS: The correlation between quantitative susceptibility mapping and dynamic contrast-enhanced quantitative perfusion suggests that the phenomena of permeability and iron deposition are related in CCM; hence, more leaky lesions also manifest a more cumulative iron burden. These techniques might be used as biomarkers to monitor the course of this disease and the effect of therapy.

Entities:  

Keywords:  biomarkers; cerebral cavernous malformations; cerebrovascular disorders; hemangioma, cavernous; hemorrhagic stroke; magnetic resonance imaging; vascular permeability

Mesh:

Substances:

Year:  2013        PMID: 24302484      PMCID: PMC4351041          DOI: 10.1161/STROKEAHA.113.003548

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  14 in total

1.  Ultrastructural pathological features of cerebrovascular malformations: a preliminary report.

Authors:  J H Wong; I A Awad; J H Kim
Journal:  Neurosurgery       Date:  2000-06       Impact factor: 4.654

2.  Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: an approach to in vivo brain iron metabolism?

Authors:  Ferdinand Schweser; Andreas Deistung; Berengar Wendel Lehr; Jürgen Rainer Reichenbach
Journal:  Neuroimage       Date:  2010-10-30       Impact factor: 6.556

3.  Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: validation and application to brain imaging.

Authors:  Ludovic de Rochefort; Tian Liu; Bryan Kressler; Jing Liu; Pascal Spincemaille; Vincent Lebon; Jianlin Wu; Yi Wang
Journal:  Magn Reson Med       Date:  2010-01       Impact factor: 4.668

4.  Ultrastructural characteristics of hemorrhagic, nonhemorrhagic, and recurrent cavernous malformations.

Authors:  Jian Tu; Marcus A Stoodley; Michael K Morgan; Kingsley P Storer
Journal:  J Neurosurg       Date:  2005-11       Impact factor: 5.115

5.  Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease.

Authors:  David A McDonald; Changbin Shi; Robert Shenkar; Rebecca A Stockton; Feifei Liu; Mark H Ginsberg; Douglas A Marchuk; Issam A Awad
Journal:  Stroke       Date:  2011-10-27       Impact factor: 7.914

6.  Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations.

Authors:  R E Clatterbuck; C G Eberhart; B J Crain; D Rigamonti
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-08       Impact factor: 10.154

7.  Validation of dynamic contrast-enhanced magnetic resonance imaging-derived vascular permeability measurements using quantitative autoradiography in the RG2 rat brain tumor model.

Authors:  Moira C Ferrier; Hemant Sarin; Steve H Fung; Bawarjan Schatlo; Ryszard M Pluta; Sandeep N Gupta; Peter L Choyke; Edward H Oldfield; David Thomasson; John A Butman
Journal:  Neoplasia       Date:  2007-07       Impact factor: 5.715

8.  Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation.

Authors:  Ping-Yen Liu; Yen-Wen Liu; Li-Jen Lin; Jyh-Hong Chen; James K Liao
Journal:  Circulation       Date:  2008-12-15       Impact factor: 29.690

9.  Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity.

Authors:  Rebecca A Stockton; Robert Shenkar; Issam A Awad; Mark H Ginsberg
Journal:  J Exp Med       Date:  2010-03-22       Impact factor: 14.307

10.  The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases.

Authors:  Kevin J Whitehead; Aubrey C Chan; Sutip Navankasattusas; Wonshill Koh; Nyall R London; Jing Ling; Anne H Mayo; Stavros G Drakos; Christopher A Jones; Weiquan Zhu; Douglas A Marchuk; George E Davis; Dean Y Li
Journal:  Nat Med       Date:  2009-01-18       Impact factor: 53.440

View more
  25 in total

Review 1.  Cavernous angiomas: deconstructing a neurosurgical disease.

Authors:  Issam A Awad; Sean P Polster
Journal:  J Neurosurg       Date:  2019-07-01       Impact factor: 5.115

2.  Characterization of Carotid Plaque Components by Quantitative Susceptibility Mapping.

Authors:  M Azuma; K Maekawa; A Yamashita; K Yokogami; M Enzaki; Z A Khant; H Takeshima; Y Asada; Y Wang; T Hirai
Journal:  AJNR Am J Neuroradiol       Date:  2019-12-26       Impact factor: 3.825

3.  Vascular permeability and iron deposition biomarkers in longitudinal follow-up of cerebral cavernous malformations.

Authors:  Romuald Girard; Maged D Fam; Hussein A Zeineddine; Huan Tan; Abdul Ghani Mikati; Changbin Shi; Michael Jesselson; Robert Shenkar; Meijing Wu; Ying Cao; Nicholas Hobson; Henrik B W Larsson; Gregory A Christoforidis; Issam A Awad
Journal:  J Neurosurg       Date:  2016-08-05       Impact factor: 5.115

4.  RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations.

Authors:  Robert Shenkar; Changbin Shi; Cecilia Austin; Thomas Moore; Rhonda Lightle; Ying Cao; Lingjiao Zhang; Meijing Wu; Hussein A Zeineddine; Romuald Girard; David A McDonald; Autumn Rorrer; Carol Gallione; Peter Pytel; James K Liao; Douglas A Marchuk; Issam A Awad
Journal:  Stroke       Date:  2016-11-22       Impact factor: 7.914

Review 5.  Neuroimaging of Cavernous Malformations.

Authors:  Maxim Mokin; Siviero Agazzi; Lowell Dawson; Christopher T Primiani
Journal:  Curr Pain Headache Rep       Date:  2017-10-13

6.  Effect of Simvastatin on Permeability in Cerebral Cavernous Malformation Type 1 Patients: Results from a Pilot Small Randomized Controlled Clinical Trial.

Authors:  Marc C Mabray; Arvind Caprihan; Jeffrey Nelson; Charles E McCulloch; Atif Zafar; Helen Kim; Blaine L Hart; Leslie Morrison
Journal:  Transl Stroke Res       Date:  2019-10-23       Impact factor: 6.829

7.  Quantitative Susceptibility Mapping of Intracerebral Hemorrhages at Various Stages.

Authors:  Shixin Chang; Jingwei Zhang; Tian Liu; Apostolos John Tsiouris; Jian Shou; Thanh Nguyen; Dana Leifer; Yi Wang; Ilhami Kovanlikaya
Journal:  J Magn Reson Imaging       Date:  2015-12-31       Impact factor: 4.813

8.  Vascular permeability in cerebral cavernous malformations.

Authors:  Abdul G Mikati; Omaditya Khanna; Lingjiao Zhang; Romuald Girard; Robert Shenkar; Xiaodong Guo; Akash Shah; Henrik B W Larsson; Huan Tan; Luying Li; Matthew S Wishnoff; Changbin Shi; Gregory A Christoforidis; Issam A Awad
Journal:  J Cereb Blood Flow Metab       Date:  2015-05-13       Impact factor: 6.200

9.  Trial Readiness in Cavernous Angiomas With Symptomatic Hemorrhage (CASH).

Authors:  Sean P Polster; Ying Cao; Timothy Carroll; Kelly Flemming; Romuald Girard; Daniel Hanley; Nicholas Hobson; Helen Kim; James Koenig; Janne Koskimäki; Karen Lane; Jennifer J Majersik; Nichol McBee; Leslie Morrison; Robert Shenkar; Agnieszka Stadnik; Richard E Thompson; Joseph Zabramski; Hussein A Zeineddine; Issam A Awad
Journal:  Neurosurgery       Date:  2019-04-01       Impact factor: 4.654

10.  PDCD10 (CCM3) regulates brain endothelial barrier integrity in cerebral cavernous malformation type 3: role of CCM3-ERK1/2-cortactin cross-talk.

Authors:  Svetlana M Stamatovic; Nikola Sladojevic; Richard F Keep; Anuska V Andjelkovic
Journal:  Acta Neuropathol       Date:  2015-09-18       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.